prognostic value of p53 in renal cell carcinoma
نویسندگان
چکیده
background and objectives: rcc is one of the most common genitourinary cancers. accurate prediction of prognosis would be valuable for adjuvant trial design, counseling and effectively scheduling follow up visits. p53 is a tumor suppressor gene that expresses a protein that involved in both cell-cycle arrests after dna damage and apoptosis. presence of mutated p53 protein in tumors has been related to poor prognosis in several malignancies such as lung, breast and prostate cancer. there is diverging results concerning the prognostic significance of mutated p53 in rcc. the aim of this study was to investigate the survival rate of rcc and the role of inactivated p53 protein as a prognostic marker in rcc. materials and methods: patients with nonmetastatic renal cell carcinoma were studied. paraffin embedded specimens of patients who underwent surgery between 1994 and 2004 at our department were chosen. all specimens were reevaluated with regard to pathological stage, nuclear grade, histological subtypes and p53 expression. p53 expression was semiquantitively evaluated on paraffin-embedded tumor tissue by immunohistochemistry. the prognostic value of parameters was tested using kaplan meier plots by the log rank test and cox regression analysis. results: this study performed on paraffin-embedded specimens of patients with nonmetastatic rcc who underwent surgery between 1994 and 2004 at our department. the mean age was 52.64yr (sd: 13.49). mean tumor size was 7.95cm (sd: 4.00). pathological stage was i in18 (39.1%), stage ii in 10(21.7%), stage iii and iv in 18(39.1%) patients. analysis revealed that 16 lesions were grade i (34.7%), 21(45.65%) grade 2, and 9(19.56%) grades 3and 4. the 10-year total survival of patients was 69.44%. in 28.3% of cases p53 staining was positive. in bivariate analysis tumor stage, tumor size, nuclear grade and p53 expression were not found to be significant prognostic factors. conclusion: p53 can not be considered as a useful prognostic parameter in renal cell carcinoma.
منابع مشابه
Prognostic value of p53 in renal cell carcinoma
Background and Objectives: RCC is one of the most common genitourinary cancers. Accurate prediction of prognosis would be valuable for adjuvant trial design, counseling and effectively scheduling follow up visits. P53 is a tumor suppressor gene that expresses a protein that involved in both cell-cycle ar...
متن کاملPrognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis
Background The prognostic value of p53 expression in renal cell carcinoma (RCC) had been investigated in previous studies; however, the results remain inconsistent. This study was performed to investigate the prognostic and clinicopathological significance of p53 protein expression in RCC. Materials and Methods Literature was identified from PubMed, Embase, Web of Science, and Cochrane databa...
متن کامل[Prognostic value of venous tumor thrombus in renal cell carcinoma].
OBJECTIVE To evaluate the prognostic value of venous tumor thrombus in renal cell carcinoma. MATERIAL AND METHODS A retrospective study of 167 patients with renal cell carcinoma and stage pT3 who underwent radical nephrectomy and extended lymphadenectomy from July 1969 to May 2008 was conducted. Patients with any kind of venous involvement were selected for the analysis (73 patients; 43.7%). ...
متن کاملPrognostic value of thrombocytosis in renal cell carcinoma.
PURPOSE We correlated platelet count to renal tumor characteristics, and evaluated the potential prognostic value of thrombocytosis in localized and metastatic tumors. MATERIALS AND METHODS A total of 804 patients operated on for a renal tumor in 2 French centers were included in this study. In all cases TNM stage, Fuhrman grade, tumor size, nodal invasion, ECOG score, histological subtype an...
متن کاملExpression Of P53 And Ki67 Proteins In Renal Cell Carcinoma And Its Relationship With Nuclear Grade
Background and Objective: Evaluation of tumor proliferative activity may provide a predicting parameter to estimate biologic aggression and a subsequent prognosis that has been evaluated in many malignancies. We have selected renal cell carcinoma (RCC) in this study. To determine tumor proliferative activity, KI67 antibody was applied and results were compared with apoptosis, applying P53 antib...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of pathologyناشر: iranian society of pathology
ISSN 1735-5303
دوره 1
شماره 2 2006
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023